NCT06058663 2026-05-13Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic CholangiocarcinomaMayo ClinicPhase 1 Recruiting16 enrolled